IBI939,Sintilimab
eli lilly,Innovent Biologics
['sintilimab', 'nsclc', 'sclc', '$ivbxf', 'innovent']
$ivbxf - innovent updates phase 1b data of ibi939 (anti-tigit monoclonal antibody) combined with sintilimab in previously untreated pd-l1-selected nsclc at the 2023 asco annual meeting 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.